Company / Free Cash Flow per Share
IRONWOOD PHARMACEUTICALS INC Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.79
FY2025
5-year range
$0.79 / $1.75
FY2021-FY2025
Trend
-54.7%
vs FY2024
Sector context
#53 of 192
Health Care
What the data says
At $0.79, IRONWOOD PHARMACEUTICALS INC's free cash flow per share ranks #53 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.73 in FY2017 to $1.75 in FY2024.
Based on SEC 10-K filings.
0.79 in FY2025 with a 3-year CAGR of -8.4%.
Declined from $1.19 to $0.79 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -8.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#53 of 192 in Health CareTop 28% of 192This company $0.79 Sector average $3.32
▼
-76.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 54.7% year-over-year.
- Ranks #53 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.79 | -54.7% |
| FY2024 | $1.75 | +47.2% |
| FY2023 | $1.19 | +15.4% |
| FY2022 | $1.03 | -36.7% |
| FY2021 | $1.63 | +460.2% |
| FY2020 | -$0.45 | -2074.6% |
| FY2019 | $0.02 | +111.0% |
| FY2018 | -$0.21 | +71.5% |
| FY2017 | -$0.73 | -230.7% |
| FY2016 | -$0.22 | +77.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026